Abbott Announces FDA Approval and U.S. Launch of Next-Generation XIENCE …
Abbott Announces FDA Approval and U.S. Launch of Next-Generation XIENCE …
Filed under: drug abuse treatment outcome study
"XIENCE Xpedition represents a powerful combination of deliverability, strong clinical data and broad availability of meaningful sizes – three factors that make this product well-suited to treat a wide range of patients," said Dr. Sharma. "The impact …
Read more on Sacramento Bee
C2N Diagnostics, InterVivo Solutions, and inviCRO Announce Formation of Pre …
Filed under: drug abuse treatment outcome study
Ultimately, the work from this collaboration intends to improve the translatability of Alzheimer's preclinical drug development to human drug development. The longitudinal study will establish … of aged dogs for therapeutic screening studies. The …
Read more on PharmiWeb.com (press release)
Support improves hepatitis C treatment completion and response rates among …
Filed under: drug abuse treatment outcome study
The best outcomes were seen in people who received therapy and support for their addiction. “The availability of support services during HCV [hepatitis C virus] treatment significantly increased the treatment completion rates … Investigators …
Read more on aidsmap